Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.21
Delayed Data
As of Sep 30
 -0.0045 / -2.10%
Today’s Change
0.20
Today|||52-Week Range
0.53
-42.15%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash13.5M18.7M9.8M10.2M
 
 
 
 
 
Short Term Investment Cash3.6M5.2M-8.9M373.2K
 
 
 
 
 
Cash & Short Term Investments13.6M18.8M32.7M23.4M
 
 
 
 
 
 
ReceivablesReceivables0.000.000.000.00--
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsPrepaid Expenses12.8K507.2K--501.2K
 
 
 
 
Other Current Assets176.0K0.00731.0K720.6K
 
 
 
 
Current Assets13.8M19.3M33.4M24.7M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross665.4K645.9K687.2K749.5K
 
 
 
 
 
Depreciation-613.2K-580.7K-609.1K-636.6K
 
 
 
 
 
Other Assets0.000.000.000.00--
Total Assets14.9M19.6M33.5M24.8M
 
 
 
 
 
 
LiabilitiesAccounts Payable851.8K251.7K706.8K774.5K
 
 
 
 
 
Accrued Expenses--240.6K1.1M1.6M
 
 
 
 
Other Current Liabilities0.00240.6K1.1M1.6M
 
 
 
 
Other Liabilities851.8K933.8K2.5M2.7M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities4.5M5.1M3.9M2.8M
 
 
 
 
 
Total Liabilities5.4M6.9M7.0M6.0M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity9.5M12.6M26.6M18.8M
 
 
 
 
 
Total Shareholder Equity9.5M12.6M26.6M18.8M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding119.4M146.7M178.3M197.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.